Studies on the polymorphism of barbital

Area of Science:

• Solid-state chemistry
• Materials science
• Pharmaceutical chemistry

Background:

• Barbital, a barbiturate derivative, is known to exist in various crystalline forms.
• Understanding the polymorphism of pharmaceutical compounds is crucial for drug formulation and stability.
• Previous studies have investigated barbital's polymorphic behavior with varying conclusions.

Purpose of the Study:

• To investigate the crystalline properties and polymorphism of barbital.
• To analyze the stability and commercial feasibility of different barbital crystal forms.
• To discuss and potentially revise conclusions from prior research on barbital polymorphism.

Main Methods:

• Isothermal crystallization from diverse solvents and sublimation techniques were employed.
• Characterization involved morphological, thermomicroscopical, thermal, IR, and density analyses.
• Initial dissolution rates and X-ray diffraction (Debye-Scherrer) were performed after prolonged storage.

Main Results:

• The formation of multiple polymorphic modifications of barbital was confirmed.
• Metastable crystal structures designated II, III, and IV exhibited significant stability.
• The stability of these metastable forms was found to be adequate for commercial viability.

Conclusions:

• Barbital's ability to form stable polymorphic modifications is re-affirmed.
• Metastable forms II, III, and IV possess practical stability, suggesting commercial potential.
• This study offers a revised perspective on barbital's solid-state properties and polymorphism.